Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
暂无分享，去创建一个
T. Haferlach | K. Götze | F. Bassermann | C. Peschel | S. Jilg | P. Jost | B. Schmidt | T. Herold | U. Höckendorf | P. Prodinger | C. Müller-Thomas | D. Hempel | V. Dill | Johanna Kauschinger | Richard T. Hauch | L. Buschhorn | T. Odinius | Richard T Hauch | Ulrike Höckendorf